Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Cochlear ( (AU:COH) ) just unveiled an update.
Cochlear Limited announced the cessation of certain securities due to the lapse of conditional rights, which were not met or became incapable of being satisfied by the end of September 2025. This cessation involves options, performance rights, and service rights, impacting the company’s issued capital and potentially influencing investor perceptions and market dynamics.
The most recent analyst rating on (AU:COH) stock is a Buy with a A$333.00 price target. To see the full list of analyst forecasts on Cochlear stock, see the AU:COH Stock Forecast page.
More about Cochlear
Cochlear Limited operates in the medical device industry, specializing in implantable hearing solutions. The company is known for its cochlear implants, bone conduction implants, and acoustic implants, focusing on improving the quality of life for individuals with hearing loss.
Average Trading Volume: 140,057
Technical Sentiment Signal: Buy
Current Market Cap: A$18.76B
For a thorough assessment of COH stock, go to TipRanks’ Stock Analysis page.